Prognostic Value of Plasma Biomarkers Among Patients With Hypertension

NCT04107584 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2019-09-27

No results posted yet for this study

Summary

Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases,and also a substantial public health problem. The purpose of the study is to investigate the association between plasma biomarkers and adverse outcomes in patients with hypertension.

Conditions

Sponsors & Collaborators

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie Du, PhD · Beijing Anzhen Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107584 on ClinicalTrials.gov